Abstract:Quenchbodies are antibodies labelled with a fluorophore that increases in intensity upon antigen binding, which makes them promising candidates for the development of diagnostic or other immunoassays requiring antigen quantification. Quenchbodies based on camelid nanobodies are particularly attractive for rapid development of immunoassays against molecular antigens of interest, due to their small size, ease of expression, high stability, rapid evolvability, and amenability to protein engineering. However, current nanobody-based quenchbodies typically display only modest fluorescence increases when binding to protein antigens (≤ 1.1–1.7-fold), with few examples reaching > 2-fold. In contrast to single-chain variable region (scFv; 32 kDa) or antigen-binding fragment (Fab; 50 kDa) quenchbodies, where semi-conserved tryptophans at the VH-VL interface quench the fluorophore, here we show that tryptophan residues in the nanobody complementarity-determining regions (CDRs) are critical to fluorescence antigen detection. This informed the development of a synthetic convex-binding nanobody library containing conserved tryptophans in the CDRs, which was used for the selection and affinity maturation of novel quenchbodies against human inflammatory cytokine interleukin 6 (IL6). Initial modelling and biochemical analyses showed that existing nanobodies for maltose-binding protein (MBP) and lysozyme could be converted into quenchbodies (Qb-MBP and Qb-Lys), with fluorescence fold-increases of 1.5 and 1.3, respectively, when recognising their cognate antigen. Rational mutational substitution of tryptophans into the CDR-region of the quenchbodies resulted in fluorescence fold-increases of 1.9 and 1.6 for Qb-MBP (Y59W/Y114W) and Qb-Lys (Y110W), respectively, supporting the importance of CDR-based tryptophans in the nanobody quenchbody mechanism. A synthetic nanobody library containing conserved CDR-based tryptophans was then created, selected, and affinity matured using a completely SNAP-display system, yielding quenchbodies against interleukin-6 (IL6) with enhanced fluorescence fold-increases of 1.5–2.4 (EC = 20–1,113 nM binding affinity). The ease and speed by which nanobody-based quenchbodies can be discovered using this completely selection strategy based on a single synthetic library, makes this a very attractive approach to develop immunoassays for detection of a wide range of molecular targets, including proteins.

Production and engineering of nanobody-based quenchbody sensors for detecting recombinant human growth hormone and its isoforms

In Vivo Bioassay of Recombinant Human Growth Hormone Synthesized Inb. Moripupae

Preparation of Specific Nanobodies and Their Application in the Rapid Detection of Nodularin-R in Water Samples

Biomarker Detection of Rhgh Doping: an Excretion Study

Immunological screening and characterization of highly specific monoclonal antibodies against 20 kDa hGH.

Simultaneous detection of myostatin-targeting monoclonal antibodies in dried blood spots and plasma using liquid chromatography-tandem mass spectrometry with field asymmetric ion mobility spectrometry

Detection of the GH analog somatrogon in sports drug testing: Immunological approaches and LC‐HRMS/MS

Diazonium-Modified Screen-Printed Electrodes for Immunosensing Growth Hormone in Blood Samples

Development of a generalisable tryptophan-optimised quenchbody biosensor based on a synthetic nanobody library

Detection of Doping with Rhgh: Excretion Study with WADA-approved Kits.

Pharmacokinetics of Recombinant Human Growth Hormone (rhGH) in Beagles by ELISA

A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone

Chemometrics-aided Surface-enhanced Raman spectrometric detection and quantification of GH and TE hormones in blood

Isoform Separation and Structural Identification of Mono-Pegylated Recombinant Human Growth Hormone (Peg-Rhgh) with Ph Gradient Chromatography.

Comparative study for purity assessment of recombinant human growth hormone using mass balance approach and amino acid-based isotope dilution mass spectrometry

Generation of Small Single Domain Nanobody Binders for Sensitive Detection of Testosterone by Electrochemical Impedance Spectroscopy

High Sensitivity Mass Spectrometric Quantification of Serum Growth Hormone by Amphiphilic Peptide Conjugation

Generation and Evaluation of Antibodies Against Human MGF E-peptide by Reverse Phase Protein Microarray and Reverse Competitive ELISA.

Design of an Antigen-Triggered Nanobody-Based Fluorescence Probe for PET Immunoassay to Detect Quinalphos in Food Samples.

Differential Intracellular Signalling Properties of the Growth Hormone Receptor Induced by the Activation of an Anti-Ghr Antibody

Exploration of Specific Nanobodies As Immunological Reagents to Detect Milk Allergen of Β-Lactoglobulin Without Interference of Hydrolytic Peptides.